Description
Eslo-Tel 2.5mg Tablet – Summary Guide
What is Eslo-Tel 2.5mg Tablet?
Eslo-Tel 2.5mg Tablet is a combination of two blood pressure-lowering medications:
Telmisartan (an angiotensin receptor blocker – ARB)
Amlodipine (a calcium channel blocker – CCB)
Together, they help relax blood vessels, improve blood flow, and reduce the workload on the heart.
Uses
✔ Treatment of Hypertension (High Blood Pressure)
Lowers blood pressure to reduce the risk of heart attack, stroke, and kidney problems.
How to Take
Dosage: As prescribed by your doctor.
How to take: Swallow whole with or without food, preferably at a fixed time daily.
Missed dose? Take it as soon as you remember. If close to the next dose, skip the missed one. Do not double the dose.
Do not stop without consulting your doctor, even if you feel well.
Side Effects (Common)
Most side effects are mild and temporary:
Swelling in ankles/feet (edema)
Dizziness, headache
Sleepiness, tiredness
Upset stomach
Sudden drop in blood pressure
When to worry? If side effects persist or worsen, consult your doctor.
Safety & Warnings
| Category | Advice |
|---|---|
| Alcohol | ❌ Unsafe – May worsen dizziness/low BP |
| Pregnancy | ❌ Avoid – Risk to unborn baby |
| Breastfeeding | ✔ Likely safe – Consult doctor |
| Driving | ⚠ Caution – May cause dizziness/sleepiness |
| Kidney Disease | ✔ Safe – No dose adjustment usually needed |
| Liver Disease | ⚠ Use with caution – Dose adjustment may be needed |
Lifestyle Tips for Better Results
✅ Eat healthy (low salt, low fat)
✅ Stay active (regular exercise)
✅ Avoid smoking & excess alcohol
✅ Monitor BP regularly
How It Works
Telmisartan blocks a hormone that tightens blood vessels.
Amlodipine relaxes blood vessels and improves blood flow.
Result: More efficient blood circulation & lower blood pressure.
Final Advice
Always follow your doctor’s instructions.
Do not stop suddenly – can cause a dangerous BP spike.
Report any unusual symptoms to your doctor.
Stay consistent for long-term heart health! ❤️







Reviews
There are no reviews yet.